1. 1) Schipper NGM, Verhoef JC, Merkus FWHM. The nasal mucociliary clearance: relevance to nasal drug delivery. Pharm. Res., 8, 807–814 (1991).
2. 2) Merkus FW, Verhoef JC, Schipper NG, Marttin E. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv. Drug Deliv. Rev., 29, 13–38 (1998).
3. 3) Inoue D, Furubayashi T, Ogawara K, Kimura T, Higaki K, Katsumi H, Sakane T, Yamamoto A, Higashi Y. In vitro evaluation of nasal mucociliary clearance using excised rat nasal septum. Biol. Pharm. Bull., 35, 889–894 (2012).
4. 4) Merkus P, Romeijn SG, Verhoef JC, Merkus FW, Schouwenburg PF. Classification of cilio-inhibiting effects of nasal drugs. Laryngoscope, 111, 595–602 (2001).
5. 5) Dimova S, Maes F, Brewster ME, Jorissen M, Noppe M, Augustijns P. High-speed digital imaging method for ciliary beat frequency measurement. J. Pharm. Pharmacol., 57, 521–526 (2005).